Home /Research /Emerging Cardioprotective Strategies Beyond Dexrazoxane: SGLT2 Inhibitors, Drug Repurposing, and Mitochondrial Approaches in Doxorubicin Cardiotoxicity.
OTHER

Emerging Cardioprotective Strategies Beyond Dexrazoxane: SGLT2 Inhibitors, Drug Repurposing, and Mitochondrial Approaches in Doxorubicin Cardiotoxicity.

Basirpour B, Mohammadi H, Hemati N, Chahardori M

Year
2026
Journal
Journal of applied toxicology : JAT

Keywords

cardioprotectiondoxorubicinSGLT2 inhibitorsmitochondriadrug repurposing

Related papers

Browse all OTHER papers